Anaphylaxis is a life-threatening systemic allergic reaction presenting various clinical manifestations. Its prevalence has increased in almost all age groups and both sexes. Food, venom, and drugs are major causes in both children and adults; a higher prevalence of food-induced anaphylaxis is noted in children, while a higher prevalence of drug-induced anaphylaxis is noted in adults. The pathogenic mechanism is mediated by immunologic and nonimmunologic mechanisms, where mast cells and basophils are key cells that release mediators. A diagnosis of anaphylaxis is mainly based on clinical symptoms and physical findings; however, an increased serum tryptase level is a useful biomarker. Epinephrine is the first-line drug to treat acute symptoms, and an epinephrine auto-injector should be prescribed for each patient. Antihistamines and systemic corticosteroids are used to relieve symptoms. This review updates current issues in the management of anaphylaxis as well as the new guidelines for proper diagnosis and treatment.
Citations
Citations to this article as recorded by
Retrospective comparison between 0.3 mg and 0.5 mg dosing of intramuscular epinephrine for anaphylaxis Caroline A. Jackson, Ryan C. Dillon, L. Montana Fleenor, Emily K. Pauw, Mary M. O'Keefe The American Journal of Emergency Medicine.2026; 99: 270. CrossRef
Exploring the anti-anaphylaxis potential of natural products: A Review Aya H. Eid, Eman S. Zaki, Miral O. Sabry, Riham A. El-Shiekh, Samar S. Khalaf Inflammopharmacology.2025; 33(5): 2589. CrossRef
Identifying patients at risk of anaphylaxis George DuToit, Pete Smith, Antonella Muraro, Adam T. Fox, Graham Roberts, Johannes Ring, Margitta Worm World Allergy Organization Journal.2024; 17(6): 100904. CrossRef
Symptomatology and Management of Adult Anaphylaxis according to Trigger: A Cross-Sectional Study Roy Khalaf, Connor Prosty, Christine McCusker, Adam Bretholz, Mohammed Kaouache, Ann E. Clarke, Judy Morris, Rodrick Lim, Edmond S. Chan, Ran D. Goldman, Andrew O’Keefe, Jennifer Gerdts, Derek K. Chu, Julia Upton, Elana Hochstadter, Jocelyn Moisan, Xun Zh International Archives of Allergy and Immunology.2024; : 1. CrossRef
A New and Different Method for Adrenaline Auto-injector Training Ahmet KAN, Veysiye Hülya ÜZEL Turkish Journal of Pediatric Disease.2022; : 1. CrossRef
Objective
Migraine headache is a chronic and disabling condition in adults. Some studies have investigated the efficacy of sodium valproate in the treatment of acute migraine, but the effectiveness and tolerability of intravenous valproate as abortive therapy remains unclear. This study aimed to evaluate the effects of sodium valproate and dexamethasone in the treatment of acute migraine.
Methods
We conducted a double-blind randomized clinical trial including 90 patients aged 18 to 65 years with acute migraine headache but no aura. Patients were randomized to receive intravenous dexamethasone (8 mg) or sodium valproate (400 mg) diluted into 4 mL of normal saline. The primary outcome measure was pain relief after 0.5, 1, 3, or 6 hours after administration. The secondary outcome criteria were the associated symptom recovery, rate of headache recurrence after 24 hours, and medication side effects. Pearson’s chi square and the t-test were employed in the data analysis.
Results
Of the 90 patients, 80 were investigated. The percentage of headache improvement at 0.5 hours after treatment was 55% and 67.5% in the sodium valproate and dexamethasone groups, respectively. Before-treatment and 0.5 hour after treatment pain severity visual analog scale scores were 9.05±0.90 and 3.8±3.09 in the sodium valproate group and 8.92±0.79 and 3.10±2.73 in the dexamethasone group, respectively. There were no significant intergroup differences.
Conclusion
This randomized clinical trial showed that the intravenous injection of sodium valproate 400 mg has similar effects to those of dexamethasone for improving acute migraine headache.
Citations
Citations to this article as recorded by
2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies Jennifer Robblee, Mia T. Minen, Benjamin W. Friedman, Miguel A. Cortel‐LeBlanc, Achelle Cortel‐LeBlanc, Serena L. Orr Headache: The Journal of Head and Face Pain.2026; 66(1): 53. CrossRef
Therapeutic Overlap Between Bipolar Disorder and Migraine: A Systematic Review of Pharmacological Trials Michel Haddad, Luiz Henrique Junqueira Dieckmann, Naielly Rodrigues da Silva, Paula Dieckmann, Thiago Wendt Viola, Jair de Jesus Mari Pharmaceuticals.2026; 19(6): 848. CrossRef
Management of 468 Status Epilepticus Cases in the Intensive Care Unit of the University Teaching Hospital of Yaoundé Ernest Dallé, Frederic Melaman Sego World Journal of Neuroscience.2026; 16(04): 357. CrossRef
Effectiveness and Safety of Pharmacologic Therapies for Migraine in the Emergency Department: A Systematic Review and Bayesian Network Meta-analysis Ian S. deSouza, Nicole Anthony, Henry Thode, Robert Allen, Jane Belyavskaya, Jessica Koos, Adam Singer Annals of Emergency Medicine.2025; 85(4): 313. CrossRef
Effectiveness of Lidocaine Infusion Versus Valproate Infusion for Pediatric Status Migrainosus Marco Antonio Ayulo, Sharaya Jenkins, Thanh Le, Sandeep Tripathi Hospital Pediatrics.2024; 14(7): 541. CrossRef
The effectiveness of parenteral agents to mitigate relapses after severe acute migraine headache presentations: A systematic review and network analysis Scott Kirkland, Jillian Meyer, Lloyd Visser, Sandra Campbell, Cristina Villa‐Roel, Benjamin W. Friedman, Nana Owusu Essel, Brian H. Rowe Headache: The Journal of Head and Face Pain.2024; 64(10): 1181. CrossRef
Steroids Provide Temporary Improvement of Refractory Pain Following Subarachnoid Hemorrhage Matthew N. Jaffa, Jamie E. Podell, Arshom Foroutan, Melissa Motta, Wan-Tsu W. Chang, Jacob Cherian, Melissa B. Pergakis, Gunjan Y. Parikh, J. Marc Simard, Michael J. Armahizer, Neeraj Badjatia, Nicholas A. Morris The Neurohospitalist.2023; 13(3): 236. CrossRef
Efficacy of IV Valproic Acid and Oral Valproic Acid Tapers for the Treatment of Pediatric Headaches in the Emergency Department Scott Rosenthal, Emma Mazzio, Hannah Wellman Gilbert, Sarah Guistolisi, Jill Marks, Jerry Jewell, Megan Straley, Lori Silveira, Ricka Messer, Jan Martin, Rakesh Mistry, Marcy E. Yonker, Craig A. Press Neurology Clinical Practice.2023;[Epub] CrossRef
All Roads Lead to the Gut: The Importance of the Microbiota and Diet in Migraine Eleonóra Spekker, Gábor Nagy-Grócz Neurology International.2023; 15(3): 1174. CrossRef
Effectiveness and safety of intravenous valproate in agitation: a systematic review Miriam Olivola, Serena Civardi, Stefano Damiani, Nicolo Cipriani, Andrea Silva, Alberto Donadeo, Pierluigi Politi, Natascia Brondino Psychopharmacology.2022; 239(2): 339. CrossRef
Sodium Valproate Versus Dopamine Antagonists for Acute Migraine in the Emergency Department: A Systematic Review J. Alexander Viau, Dilan Patel, Wei Cheng, Miguel Cortel-LeBlanc, Avik Nath, Jeffrey J. Perry Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2022; 49(5): 688. CrossRef
Stroke-Like Migraine after Radiation Treatment Syndrome in Children with Cancer Qurratulain S. Ahmed, Zsila S. Sadighi, John T. Lucas, Raja B. Khan Journal of Pediatric Neurology.2022; 20(04): 304. CrossRef
Intravenous ibuprofen versus sodium valproate in acute migraine attacks in the emergency department: A randomized clinical trial Sinem Dogruyol, Sultan Tuna Akgol Gur, Ilker Akbas, Meryem Betos Kocak, Abdullah Osman Kocak, Mustafa Ceylan, Davut Tekyol The American Journal of Emergency Medicine.2022; 55: 126. CrossRef
Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment Jinfeng Duan, Rongmei Yang, Wenwen Lu, Lingfei Zhao, Shaohua Hu, Chenxia Hu Frontiers in Psychiatry.2021;[Epub] CrossRef
Intravenous sodium valproate for acute migraine in the emergency department: A meta‐analysis Fengzhi Wang, Hemin Zhang, Liyu Wang, Yumeng Cao, Qiu He Acta Neurologica Scandinavica.2020; 142(6): 521. CrossRef
Prosopometamorphopsia and Visual Field Defect Improved by Valproic acid in a CADASIL Patient Jin Hwangbo, Jae Wook Cho, Sun-Hye Jung, Jin-Hong Shin, Na-Yeon Jung Journal of the Korean Neurological Association.2019; 37(4): 368. CrossRef
Identifying, locating, diagnosing, and treating small foreign bodies (FBs) in soft tissues is a challenge for emergency physicians in the emergency department. Additionally, potential complications owing to the remnant FBs are medico-legally significant. The efficacy of conventional imaging methods such as radiography, computed tomography, and ultrasonography are largely limited in visualizing FBs<2-mm. The slit-lamp microscope, still unfamiliar to some emergency physicians, could be used to facilitate the treatment of FBs impacted in soft tissues. In this paper, we present a case that would have been difficult to treat without the help of the slit-lamp microscope; the patient presented with numerous particulate facially impacted FBs that were too small to be observed under plain sight or with radiography. Based on our experience, the slitlamp microscope could be a useful tool for treating patients with miniscule and stubborn impacted FBs in the emergency department.